Search research articles
Contact Us
Filters
Showing results (31-40 of 56) with videos related to
Page
of 6
Sort By:
Advanced Materials (Deerfield Beach, Fla.)
|
May 10, 2025
Mechanostimulatory Platform for Improved CAR T Cell Immunotherapy
Abed Al-Kader Yassin, Carlos Ureña Martin, Guillaume Le Saux, et al.
Cell Reports
|
July 19, 2023
High FOXA1 levels induce ER transcriptional reprogramming, a pro-metastatic secretome, and metastasis in endocrine-resistant breast cancer
Xiaoyong Fu, Resel Pereira, Chia-Chia Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 30, 2020
Acquired FGFR and FGF Alterations Confer Resistance to Estrogen Receptor (ER) Targeted Therapy in ER<sup>+</sup> Metastatic Breast Cancer
Pingping Mao, Ofir Cohen, Kailey J Kowalski, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 13, 2019
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer
Xiaoyong Fu, Resel Pereira, Carmine De Angelis, et al.
Nature Cell Biology
|
July 3, 2019
Subclonal cooperation drives metastasis by modulating local and systemic immune microenvironments
Michalina Janiszewska, Doris P Tabassum, Zafira Castaño, et al.
Cancer Cell
|
February 14, 2018
Allele-Specific Chromatin Recruitment and Therapeutic Vulnerabilities of ESR1 Activating Mutations
Rinath Jeselsohn, Johann S Bergholz, Matthew Pun, et al.
Nature Cell Biology
|
March 5, 2024
Author Correction: Subclonal cooperation drives metastasis by modulating local and systemic immune microenvironments
Michalina Janiszewska, Doris P Tabassum, Zafira Castaño, et al.
Nature Communications
|
April 20, 2022
ESR1 mutant breast cancers show elevated basal cytokeratins and immune activation
Zheqi Li, Olivia McGinn, Yang Wu, et al.
Cancer Research
|
February 8, 2023
Mutated HRAS Activates YAP1-AXL Signaling to Drive Metastasis of Head and Neck Cancer
Sankar Jagadeeshan, Manu Prasad, Mai Badarni, et al.
Cancer Cell
|
February 13, 2019
KDM5 Histone Demethylase Activity Links Cellular Transcriptomic Heterogeneity to Therapeutic Resistance
Kunihiko Hinohara, Hua-Jun Wu, Sébastien Vigneau, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 56) with videos related to
Sort By:
Page
of 6
Advanced Materials (Deerfield Beach, Fla.)
|
May 10, 2025
Mechanostimulatory Platform for Improved CAR T Cell Immunotherapy
Abed Al-Kader Yassin, Carlos Ureña Martin, Guillaume Le Saux, et al.
Cell Reports
|
July 19, 2023
High FOXA1 levels induce ER transcriptional reprogramming, a pro-metastatic secretome, and metastasis in endocrine-resistant breast cancer
Xiaoyong Fu, Resel Pereira, Chia-Chia Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 30, 2020
Acquired FGFR and FGF Alterations Confer Resistance to Estrogen Receptor (ER) Targeted Therapy in ER<sup>+</sup> Metastatic Breast Cancer
Pingping Mao, Ofir Cohen, Kailey J Kowalski, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 13, 2019
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer
Xiaoyong Fu, Resel Pereira, Carmine De Angelis, et al.
Nature Cell Biology
|
July 3, 2019
Subclonal cooperation drives metastasis by modulating local and systemic immune microenvironments
Michalina Janiszewska, Doris P Tabassum, Zafira Castaño, et al.
Cancer Cell
|
February 14, 2018
Allele-Specific Chromatin Recruitment and Therapeutic Vulnerabilities of ESR1 Activating Mutations
Rinath Jeselsohn, Johann S Bergholz, Matthew Pun, et al.
Nature Cell Biology
|
March 5, 2024
Author Correction: Subclonal cooperation drives metastasis by modulating local and systemic immune microenvironments
Michalina Janiszewska, Doris P Tabassum, Zafira Castaño, et al.
Nature Communications
|
April 20, 2022
ESR1 mutant breast cancers show elevated basal cytokeratins and immune activation
Zheqi Li, Olivia McGinn, Yang Wu, et al.
Cancer Research
|
February 8, 2023
Mutated HRAS Activates YAP1-AXL Signaling to Drive Metastasis of Head and Neck Cancer
Sankar Jagadeeshan, Manu Prasad, Mai Badarni, et al.
Cancer Cell
|
February 13, 2019
KDM5 Histone Demethylase Activity Links Cellular Transcriptomic Heterogeneity to Therapeutic Resistance
Kunihiko Hinohara, Hua-Jun Wu, Sébastien Vigneau, et al.
Page
of 6